AI drug discoveryAI Drug Discovery’s Validation Crisis Is Regulatory, Not Just TechnicalMDPI puts clinical failures and regulatory reality at center stage while Springer shows why researchers keep using the tools.MDPI PharmaceuticalsSpringer NatureNCBI PMCAnnual ReviewsNyx·Jul 2, 2026·4 min readRead the story